BioSpace News Archive

Acumen Pharmaceuticals, Inc. announced that Frontiers in Neuroscience published a summary of preclinical evidence supporting ACU193, a monoclonal antibody that selectively targets toxic soluble Aβ oligomers for the potential treatment of early Alzheimer’s disease.

Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, will report financial results for the first quarter 2022 after market close on Monday, May 9, 2022.

Abbott (NYSE: ABT), CamDiab and Ypsomed today announced that they are partnering to develop and commercialize an integrated automated insulin delivery (AID) system to help lessen the burden of round-the-clock diabetes management for people with diabetes.

ContraFect Corporation announces presentation data showing DLA CF-370 is highly efficacious in a rabbit pneumonia model of a particularly hard-to-treat, extensively-drug-resistant strain of Pseudomonas aeruginosa, and also has the ability to both avoid antimicrobial resistance and suppress antibiotic resistance to commonly-used antibiotics in vitro.

IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its first quarter 2022 financial and operating results on Wednesday, May 4, 2022.

Comera Life Sciences, Inc. today announced that Robert P. Mahoney, Ph.D., Chief Scientific Officer, will present at the PEGS Boston Conference & Expo, being held May 2-6, 2022, in-person.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, May 5, 2022 to report financial results for the quarter ended March 31, 2022 and discuss recent corporate highlights.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked fifth in overall corporate reputation among patient groups that have worked directly with the company and seventh among patient groups who were familiar with the company.

Sonendo , Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave® System, is participating in the American Association of Endodontists’ (AAE) Annual Meeting taking place from April 27-30, 2022 in Phoenix, AZ.

Visus Therapeutics Inc. today announced that it will present new scientific data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting , to be held May 1-4, 2022 in Denver, Colorado.